Recent Updates
Recently added Catalysts
KURA Positive Sentiment Score: 65/100

Kura Oncology to Report First Quarter 2024 Financial Results

Thursday, April 25, 2024 1 min read
Key Takeaway: Kura Oncology, a clinical-stage biopharmaceutical company, will report its first quarter 2024 financial results on May 2, 2024. The announcement was made on April 25, 2024, and follows the company's commitment to developing precision medicines for cancer. Management will host a webcast and conference call at 4:30 p.m. ET to discuss the results and provide an update on corporate activities. This event underscores Kura's ongoing communication with its investors and stakeholders.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kura Oncology is set to report its first quarter 2024 financial results, indicating ongoing business activities.
  • The webcast for the financial results and corporate update shows transparency and engagement with investors.
  • Kura is focused on precision medicines for cancer treatment, highlighting its commitment to innovative healthcare solutions.

Full Press Release Details

SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report first quarter 2024 financial results after the close of U.S. financial markets on Thursday, May 2, 2024. Kura’s management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT that day to discuss the financial results and provide a corporate update.
The live call may be accessed by dialing (888) 886-7786 for domestic callers and (416) 764-8658 for international callers. A live webcast and archived replay of the event will be available here or online from the investor relations section of the company website at www.kuraoncology.com.
Executive Vice President, Investor Relations &
Corporate Communications
pete@kuraoncology.com
Alexandra Weingarten
Associate Director, Investor Relations &
Corporate Communications
alexandra@kuraoncology.com

Tags

acute myeloid leukemia

Frequently Asked Questions

When will Kura Oncology report its Q1 2024 financial results?

Kura Oncology will report its Q1 2024 financial results on May 2, 2024.

What time is Kura's investor call on May 2, 2024?

The investor call will be at 4:30 p.m. ET / 1:30 p.m. PT.

How can I access Kura's live conference call?

Dial (888) 886-7786 for domestic or (416) 764-8658 for international access.

Where can I find the webcast for Kura's financial results?

The webcast and replay will be available on Kura's investor relations website.

Who should I contact for investor relations at Kura Oncology?

Contact Pete or Alexandra Weingarten via their provided email addresses.

Tags: KURA Viatris Investor Conferences Healthcare Kura Oncology Q1 2024 results financial report precision medicine cancer treatment
Last updated: Apr 25, 2024